🎧 NEW EPISODE ALERT! Immunobuddies – Real-World Complex Cases (Part 5) with Dr Jay Naik, Dr @RickyFrazer1 , and Dr @AOlssonBrown . Immunotherapy doesn’t always follow the rulebook — and that’s exactly what makes this Real-World Complex Cases series so valuable. 💡 In this

🌍 The Immunobuddies are in Berlin! 🇩🇪 We’re excited to be at the ESMO Congress 2025 — come and say hi if you spot us around the venue! It’s always great to catch up with fellow #Oncology and #Immunotherapy enthusiasts. 🎙️ And while we’re here, our latest Immunobuddies episode

Do come and join us! The case conundrums series takes complex cases and scenarios and gives a series of principles and approaches you will be able to use in your daily clinic practice whilst making this essential learning fun and interactive! ❤️

🎙️ New Immunobuddies Mini-Series: Real-World Complex Cases 🚨 Ever wondered how experts navigate the trickiest immunotherapy scenarios in practice? 💭❓ Join Dr Ricky Frazer, Dr Anna Olsson-Brown, and guest Dr Jay Naik as they unpack real patient cases from the front line of

Calling all oncology professionals: We need your voice. How are immune checkpoint inhibitors affecting fertility? We don’t know enough—and that needs to change. If you work in immuno-oncology, help us understand UK practices around fertility counselling & preservation. The

🚨🔊 New Podcast Episode – Immunobuddies Ep.159 🎙️ Triple Negative Breast Cancer: Role of Complete Pathological Response & Impact on Surgery In this episode, we dive into: ✅ Why complete pathological response (pCR) matters in TNBC ✅ The challenges of toxicity and prolonged

Catch up with the latest Immunobuddies episode! 🎧 Episode 158: Triple Negative Breast 2 – Role of Immunotherapy in Neoadjuvant and Adjuvant Space Dr Ricky Frazer and Dr Anna Olsson-Brown are joined by Dr Peter Hall to explore: 🔹 The role of immunotherapy alongside

🌟 Excellence in Immuno-Oncology Award – Applications Now Open! 🌟 The Immuno-Oncology Clinical Network (IOCN) is proud to launch the Excellence in Immuno-Oncology Award. 🏆 Four winners will receive a complimentary place at the IOCN Case Conundrums Study Day in Birmingham on

🔊 New Episode Alert! 🚨 🎙 Immunobuddies Podcast – Episode 157 Overview of Triple Negative Breast Cancer with Dr Peter Hall Triple Negative Breast Cancer (TNBC) accounts for around 10–15% of breast cancers, but remains one of the most challenging to treat. In this episode, Dr

🚨Join us for our next study day! 🧠Advancing the management of Immunotherapy Toxicities through Case Conundrums! 🗓️ Friday 3rd October 2025 | Birmingham 📷 6.5 CPD hrs | £150 🎓 Get your tickets here: https://t.co/pZpxH8P0J6 Or Contact Us: https://t.co/KEXVTqEDne

🚨 New Episode Alert! 🎙️ 🗣️In Episode 156 of Immunobuddies, we sit down with Professor Rob Jones, Research Lead for Advanced Colorectal Cancer, to explore 🚑 cancer vaccines from a surgical perspective. 🔹 Inside the BioNTech iNeST trial for personalised mRNA vaccines 🔹 Why

🚨 NEW EPISODE ALERT 🚨 🎙️ Episode 155: Surgical Primer – Final Part! 💉 Putting a Knife into the Heart of Immunotherapy with Prof Rob Jones, Research Lead for Advanced Colorectal Cancer In this final part of our Surgical Primer series, we dive into the surgical realities of

🧠💥 IO Toxicities – Case Studies Education Day! 📅 3 Oct 2025 | Birmingham 🎓 6.5 CPD hrs | £150 🎯 Expert tips, tricky cases & top networking. 🚀 Submit your abstract by 22nd August! https://t.co/xeOVDjkota 🔗 Find out more and book now:

🎙 New Episode Alert! 🚨 "Surgical Primer – Putting a knife into the heart of immunotherapy" ✂️💉 This week on The Immunobuddies, we’re joined by Professor Rob Jones , Research Lead for Advanced Colorectal Cancer, to explore how surgery and immunotherapy intersect in cancer

🎙️ New Immunobuddies Episode! EP153: Subcutaneous Immunotherapy – Future Potential What could the future of cancer treatment look like? 💉✨ Jo Parkes & Dr Vasiliki Michalarea return to explore how subcutaneous (SC) immunotherapy might transform care delivery, reduce hospital

🎓IOCN Advance the management of immunotherapy toxicities through case conundrums 📅 Friday 3rd October 2025 | 🕤 09:30–16:30 📍 Macdonald Burlington Hotel, Birmingham 🎟️ Tickets: £150pp | CPD Accredited (6.5 hours) 🔗 Book now: https://t.co/O7UGji6tdd 💥 Join us for a day of

🚨As part of the E-IMMUNE research programme, Dr Anna Olsson-Brown, Professor Janet Brown and Dr Joanne Bird are leading a group looking into the various elements of immunotherapy tolerability and developing a digital platform to monitor the late effects of immunotherapy

🚨 New Episode Out Now! 🎧 💉Subcutaneous Immunotherapy – What are the logisitics? 🏥💉 In Episode 152, the Immunobuddies are back with Jo Parkes @jpar088 and Dr Vasiliki Michalarea to tackle the real-world logistics of rolling out subcutaneous immunotherapy in clinical

🎧 NEW EPISODE OUT NOW! Is Subcutaneous Immunotherapy a Game-Changer or Just Hype? 💉🤔 Join @RickyFrazer1 & @AOlssonBrown as they unpack the science, promise & pitfalls of Subcutaneous Immunotherapy with special guests Jo Parkes & Dr Vasiliki Michalarea. We’re diving into:

🎙️ “Managing HLH: The Final Chapter” 🚨 Episode 150 is live! After breaking down the diagnosis, the H-score, and multi-system involvement… 👉 We’re wrapping up our HLH series with a deep dive into real-world management strategies. 💉 When to treat? 🧪 What to monitor? 🤝 And